Luminescence Markers Worthy of Continuous Attention in the Future

The immunoassay method involves the widest range of items among all fields of medical detection; with the development of biomedical research, especially genomics and post-genomics results (high-resolution two-dimensional electrophoresis combined with mass spectrometry) which highly promote the research on disease-related markers, more and more items will be detected via immunoassay in the medical practice. In addition to the currently available reagent menu, novel clinically valuable items such as growth stimulator-expressed gene 2 protein (ST2), oxidized low-density lipoprotein (Ox-LDL), and (HBerAg) are also being continuously tested or applied to the diagnosis, stratification, prognosis, and efficacy prediction of diseases.

Last: 4.2  Main Automatic Chemiluminescence Immunoassay Detection Items and Markets in China

Next: Immunoassay Outlook